BACKGROUND: Due to the underlying diseases and the need for immunosuppression, patients after lung transplantation are particularly at risk for gastrointestinal (GI) complications that may negatively influence long-term outcome. The present study assessed the incidences and impact of GI complications after lung transplantation and aimed to identify risk factors. METHODS: Retrospective analysis of all 227 consecutively performed single- and double-lung transplantations at the University hospitals of Lausanne and Geneva was performed between January 1993 and December 2010. Logistic regressions were used to test the effect of potentially influencing variables on the binary outcomes overall, severe, and surgery-requiring complications, followed by a multiple logistic regression model. RESULTS: Final analysis included 205 patients for the purpose of the present study, and 22 patients were excluded due to re-transplantation, multiorgan transplantation, or incomplete datasets. GI complications were observed in 127 patients (62%). Gastro-esophageal reflux disease was the most commonly observed complication (22.9%), followed by inflammatory or infectious colitis (20.5%) and gastroparesis (10.7%). Major GI complications (Dindo/Clavien III-V) were observed in 83 (40.5%) patients and were fatal in 4 patients (2.0%). Multivariate analysis identified double-lung transplantation (p = 0.012) and early (1993-1998) transplantation period (p = 0.008) as independent risk factors for developing major GI complications. Forty-three (21%) patients required surgery such as colectomy, cholecystectomy, and fundoplication in 6.8, 6.3, and 3.9% of the patients, respectively. Multivariate analysis identified Charlson comorbidity index of ≥3 as an independent risk factor for developing GI complications requiring surgery (p = 0.015). CONCLUSION: GI complications after lung transplantation are common. Outcome was rather encouraging in the setting of our transplant center.
BACKGROUND: Due to the underlying diseases and the need for immunosuppression, patients after lung transplantation are particularly at risk for gastrointestinal (GI) complications that may negatively influence long-term outcome. The present study assessed the incidences and impact of GI complications after lung transplantation and aimed to identify risk factors. METHODS: Retrospective analysis of all 227 consecutively performed single- and double-lung transplantations at the University hospitals of Lausanne and Geneva was performed between January 1993 and December 2010. Logistic regressions were used to test the effect of potentially influencing variables on the binary outcomes overall, severe, and surgery-requiring complications, followed by a multiple logistic regression model. RESULTS: Final analysis included 205 patients for the purpose of the present study, and 22 patients were excluded due to re-transplantation, multiorgan transplantation, or incomplete datasets. GI complications were observed in 127 patients (62%). Gastro-esophageal reflux disease was the most commonly observed complication (22.9%), followed by inflammatory or infectious colitis (20.5%) and gastroparesis (10.7%). Major GI complications (Dindo/Clavien III-V) were observed in 83 (40.5%) patients and were fatal in 4 patients (2.0%). Multivariate analysis identified double-lung transplantation (p = 0.012) and early (1993-1998) transplantation period (p = 0.008) as independent risk factors for developing major GI complications. Forty-three (21%) patients required surgery such as colectomy, cholecystectomy, and fundoplication in 6.8, 6.3, and 3.9% of the patients, respectively. Multivariate analysis identified Charlson comorbidity index of ≥3 as an independent risk factor for developing GI complications requiring surgery (p = 0.015). CONCLUSION:GI complications after lung transplantation are common. Outcome was rather encouraging in the setting of our transplant center.
Authors: E I Lubetkin; D A Lipson; H I Palevsky; R Kotloff; J Morris; G T Berry; G Tino; E F Rosato; J A Berlin; A B Wurster; L R Kaiser; G R Lichtenstein Journal: Am J Gastroenterol Date: 1996-11 Impact factor: 10.864
Authors: Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2012-10 Impact factor: 10.247
Authors: Nima Abbassi-Ghadi; Sacheen Kumar; Billy Cheung; Anne McDermott; Alison Knaggs; Emmanouil Zacharakis; Krishna Moorthy; Martin Carby; George B Hanna Journal: J Heart Lung Transplant Date: 2013-03-27 Impact factor: 10.247
Authors: William S Richardson; Walter J Surowiec; Kristine M Carter; Todd P Howell; Mandeep R Mehra; John C Bowen Journal: Ann Surg Date: 2003-02 Impact factor: 12.969
Authors: Eric S Larson; Hassan A Khalil; Anne Y Lin; Marcia Russell; Abbas Ardehali; David Ross; James Yoo Journal: J Surg Res Date: 2014-05-11 Impact factor: 2.192
Authors: Subroto Paul; Cesar E Escareno; Kerri Clancy; Michael T Jaklitsch; Raphael Bueno; David B Lautz Journal: J Heart Lung Transplant Date: 2009-05 Impact factor: 10.247
Authors: Su Hwan Lee; Moo Suk Park; Jin Gu Lee; Joo Han Song; Kyung Soo Chung; Ji Ye Jung; Eun Young Kim; Young Sam Kim; Se Kyu Kim; Joon Chang; Hyo Chae Paik; Song Yee Kim Journal: J Thorac Dis Date: 2017-12 Impact factor: 2.895
Authors: Henriette Heinrich; Anne Neuenschwander; Stefan Russmann; Benjamin Misselwitz; Christian Benden; Macé M Schuurmans Journal: BMJ Open Respir Res Date: 2016-12-23
Authors: Jutta Keller; Gabrio Bassotti; John Clarke; Phil Dinning; Mark Fox; Madhusudan Grover; Per M Hellström; Meiyun Ke; Peter Layer; Carolina Malagelada; Henry P Parkman; S Mark Scott; Jan Tack; Magnus Simren; Hans Törnblom; Michael Camilleri Journal: Nat Rev Gastroenterol Hepatol Date: 2018-04-06 Impact factor: 46.802